Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5407012, 10 pages
https://doi.org/10.1155/2017/5407012
Research Article

Susceptibility of In Vitro Melanoma Skin Cancer to Photoactivated Hypericin versus Aluminium(III) Phthalocyanine Chloride Tetrasulphonate

Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein 2028, South Africa

Correspondence should be addressed to H. Abrahamse; az.ca.ju@esmaharbah

Received 13 December 2016; Revised 5 July 2017; Accepted 9 August 2017; Published 25 September 2017

Academic Editor: Xin-yuan Guan

Copyright © 2017 I. M. Ndhundhuma and H. Abrahamse. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Weinberg, “How cancer arises.,” Scientific American, vol. 275, no. 3, pp. 62–70, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Pelengaris and M. Khan, The Molecular Biology of Cancer, Wiley-Blackwell, 2006.
  3. A. R. Rhodes, “Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer?” Cancer, vol. 75, no. 2 S, pp. 613–636, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. B. K. Armstrong and A. Kricker, “The epidemiology of UV induced skin cancer,” Journal of Photochemistry and Photobiology B: Biology, vol. 63, no. 1–3, pp. 8–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. N. Saladi and A. N. Persaud, “The causes of skin cancer: a comprehensive review,” Drugs of Today, vol. 41, no. 1, pp. 37–53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Kim, R. N. Amaria, C. Spencer, A. Reuben, Z. A. Cooper, and J. A. Wargo, “Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma,” Cancer Biology and Medicine, vol. 11, no. 4, pp. 237–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Zigler, G. J. Villares, D. C. Lev, V. O. Melnikova, and M. Bar-Eli, “Tumor immunotherapy in melanoma: Strategies for overcoming mechanisms of resistance and escape,” American Journal of Clinical Dermatology, vol. 9, no. 5, pp. 307–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. T. Wan and J. Y. Lin, “Current evidence and applications of photodynamic therapy in dermatology,” Clinical, Cosmetic and Investigational Dermatology, vol. 7, pp. 145–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. E. O'Connor, W. M. Gallagher, and A. T. Byrne, “Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy,” Photochemistry and Photobiology, vol. 85, no. 5, pp. 1053–1074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Jain, V. Bhardwaj, and S. Yadav, “Photosensitizer: Role in Therapy,” Archives of Applied Science Research, vol. 2, pp. 196–206, 2010. View at Google Scholar
  11. M. H. Gold, Photodynamic Therapy in Dermatology, Springer, New York, NY, USA, 2011. View at Publisher · View at Google Scholar
  12. W. Laffers, A.-C. Busse, J. Mahrt et al., “Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro,” European Archives of Otorhinolaryngology, vol. 272, no. 3, pp. 711–718, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kolarova, P. Nevrelova, R. Bajgar, D. Jirova, K. Kejlova, and M. Strnad, “In vitro photodynamic therapy on melanoma cell lines with phthalocyanine,” Toxicology in Vitro, vol. 21, no. 2, pp. 249–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. M. Davids, B. Kleemann, D. Kacerovská, K. Pizinger, and S. H. Kidson, “Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells,” Journal of Photochemistry and Photobiology B: Biology, vol. 91, no. 2-3, pp. 67–76, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Sekkat, H. Van Den Bergh, T. Nyokong, and N. Lange, “Like a bolt from the blue: Phthalocyanines in biomedical optics,” Molecules, vol. 17, no. 1, pp. 98–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. Peng, G. W. Farrants, K. Madslien et al., “Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line,” International Journal of Cancer, vol. 49, no. 2, pp. 290–295, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Ndhundhuma, C. Hauser, C. Scalfi-Happ, A. Rück, and R. Steiner, “Subcellular co-localization of aluminum (III) phthalocyanine chloride tetrasulphonate with fluorescent markers in the human melanoma cell-line HT-144,” Medical Laser Application, vol. 26, no. 3, pp. 93–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. S. Chung, C. K. Rhee, K. H. Kim et al., “Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma,” Laryngoscope, vol. 110, no. 8, pp. 1312–1316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Agostinis, A. Vantieghem, W. Merlevede, and P. A. M. De Witte, “Hypericin in cancer treatment: More light on the way,” International Journal of Biochemistry and Cell Biology, vol. 34, no. 3, pp. 221–241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. W. M. Sharman, C. M. Allen, and J. E. Van Lier, “Photodynamic therapeutics: basic principles and clinical applications,” Drug Discovery Today, vol. 4, no. 11, pp. 507–517, 1999. View at Publisher · View at Google Scholar
  21. K. Kalka, N. Ahmad, T. Criswell, D. Boothman, and H. Mukhtar, “Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors,” Cancer Research, vol. 60, no. 21, pp. 5984–5987, 2000. View at Google Scholar · View at Scopus
  22. C. Hadjur, M.-J. Richard, M.-O. Parat, P. Jardon, and A. Favier, “Photodynamic effects of hypericin on lipid peroxidation and antioxidant status in melanoma cells,” Photochemistry and Photobiology, vol. 64, no. 2, pp. 375–381, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. N. L. Oleinick and H. H. Evans, “The photobiology of photodynamic therapy: cellular targets and mechanisms,” Radiation Research, vol. 150, no. 5, pp. S146–S156, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. A. P. Castano, T. N. Demidova, and M. R. Hamblin, “Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localization,” Photodiagnosis and Photodynamic Therapy, vol. 1, no. 4, pp. 279–293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Sanovic, B. Krammer, S. Grumboeck, and T. Verwanger, “Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin,” International Journal of Oncology, vol. 35, no. 4, pp. 921–939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. Castano, T. N. Demidova, and M. R. Hamblin, “Mechanisms in photodynamic therapy: part two—cellular signaling, cell metabolism and modes of cell death,” Photodiagnosis and Photodynamic Therapy, vol. 2, no. 1, pp. 1–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Mroz, A. Yaroslavsky, G. B. Kharkwal, and M. R. Hamblin, “Cell death pathways in photodynamic therapy of cancer,” Cancers, vol. 3, no. 2, pp. 2516–2539, 2011. View at Publisher · View at Google Scholar · View at Scopus